Horizon Therapeutics to Present at JMP Securities Healthcare Focus ConferenceSKOKIE, Ill. , October 1, 2008 - Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced today that Timothy P. Walbert, president and chief executive officer, will present a corporate overview at the JMP Securities Healthcare Focus Conference in New York on Tuesday, October 7 at 9 a.m. ET at the Le Parker Meridien Hotel.

About Horizon Therapeutics
Horizon Therapeutics, Inc. is a late-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of mild-to-moderate pain and arthritis. Horizon's clinical portfolio includes innovative combination therapies in early- and late-stage development that are designed to improve safety, efficacy and patient compliance. For more information about the company and its products, please visit www.horizontherapeutics.com.

Contact:
Geoff Curtis
WeissComm Partners, Inc.
312-284-4701
gcurtis@wcpglobal.com